Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
Rich Racine uses his 30 plus years of IP experience to develop winning legal strategies for clients that allow them to achieve their business objectives in a cost-effective and efficient manner. Having served as the firm’s managing partner and chairman for many years, he brings a deep understanding of the interplay between legal and business issues to his legal practice.
Rich’s practice involves virtually all aspects of intellectual property law, with a particular emphasis on district court patent litigation, due diligence investigations, opinion matters, and patent portfolio development and management. He works closely with clients in a variety of technologies to develop and execute strategies that best obtain, protect, and enforce their intellectual property.
Rich has extensive litigation experience and has had key responsibilities in federal district court cases, from the initial pleading stage through discovery, motions, claim construction, and trial. Much of his litigation practice involves complex and significant patent infringement disputes. Rich was recognized by The Legal 500 U.S. for ITC patent litigation work. He has had lead roles in Abbreviated New Drug Application (ANDA) litigations for blockbuster pharmaceuticals and has a keen understanding of the interplay of the Hatch-Waxman Act, the patent laws, and the Food and Drug Administration (FDA) rules.
Rich also has an extensive and sophisticated opinion and due diligence practice involving a wide range of technologies, with a specific focus in the pharmaceutical and chemical areas. He has rendered countless opinions on complex patent validity, enforceability, and infringement questions. Many of these opinions were in anticipation of litigation or as part of mergers, acquisitions, due diligence investigations, patent portfolio assessments and development, or licensing opportunities.
Rich lectures frequently on patent protection and litigation, especially opinion and due diligence practice, and the American Invents Act (AIA). He has chaired and lectured various meetings and programs hosted by organizations that include the Practice Resources Group, Managing Intellectual Property, Intellectual Property Owners Association, the Biotechnology Innovation Organization, the Hildebrandt Institute, the Food and Drug Law Institute, CEC Fortune 500 Conference, and the Southwestern Legal Foundation. He also lectures and provides seminars on a yearly basis in China.
Rich has held numerous management and leadership roles in the firm. He served as the firms chairman, following his tenure as managing partner. He has been a member of the management and compensation committees, and led the firm’s chemical practice group for two terms.